Membrane estrogen and glucocorticoid receptors - Implications for hormonal control of immune function and autoimmunity

Cheryl S. Watson, Bahiru Gametchu

    Research output: Contribution to journalArticle

    41 Citations (Scopus)

    Abstract

    Membrane steroid receptors (mSRs) have recently re-emerged as candidates for mediating steroid effects which do not fit the paradigm of nuclear transcription factor mechanisms. We have studied two steroid-binding classes of mSRs, and have noted striking similarities in their characteristics (immunocytochemical appearance, biochemical properties, proteolytic sensitivity, signaling pathways, regulation, and molecular origins). These observations strengthen the conclusion that mSRs can be modified versions of intracellular steroid receptors. The membrane estrogen receptors (mERs) we studied are involved in estrogen-induced release of prolactin. Membrane glucocorticoid receptors (mGRs) in both mouse and human lymphoma cells are necessary for the initiation of glucocorticoid-induced therapeutic apoptosis which is related to the developmental phenomenon of thymic involution. Diseases of autoimmunity such as systemic lupus erythematosus and arthritis are related to estrogen status. Since both of these mSRs have recently been found in both normal and cancerous lymphoid cells, actions of these mSRs may have important consequences for functions and diseases of the immune system. Therefore, the study of these forms of steroid receptors may present novel therapeutic opportunities for the use of steroids and steroid analogs.

    Original languageEnglish (US)
    Pages (from-to)1049-1063
    Number of pages15
    JournalInternational Immunopharmacology
    Volume1
    Issue number6
    DOIs
    StatePublished - Jun 2001

    Fingerprint

    Steroid Receptors
    Glucocorticoid Receptors
    Autoimmunity
    Estrogen Receptors
    Membranes
    Steroids
    Estrogens
    Immune System Diseases
    Therapeutic Uses
    Systemic Lupus Erythematosus
    Prolactin
    Glucocorticoids
    Arthritis
    Lymphoma
    Transcription Factors
    Cell Membrane
    Lymphocytes
    Apoptosis

    Keywords

    • Cancer
    • Development
    • Non-genomic
    • Prolactin release
    • Steroid receptors
    • Therapeutic apoptosis

    ASJC Scopus subject areas

    • Immunology
    • Pharmacology

    Cite this

    Membrane estrogen and glucocorticoid receptors - Implications for hormonal control of immune function and autoimmunity. / Watson, Cheryl S.; Gametchu, Bahiru.

    In: International Immunopharmacology, Vol. 1, No. 6, 06.2001, p. 1049-1063.

    Research output: Contribution to journalArticle

    @article{897bdf763b9648bcb8e27c29fff45963,
    title = "Membrane estrogen and glucocorticoid receptors - Implications for hormonal control of immune function and autoimmunity",
    abstract = "Membrane steroid receptors (mSRs) have recently re-emerged as candidates for mediating steroid effects which do not fit the paradigm of nuclear transcription factor mechanisms. We have studied two steroid-binding classes of mSRs, and have noted striking similarities in their characteristics (immunocytochemical appearance, biochemical properties, proteolytic sensitivity, signaling pathways, regulation, and molecular origins). These observations strengthen the conclusion that mSRs can be modified versions of intracellular steroid receptors. The membrane estrogen receptors (mERs) we studied are involved in estrogen-induced release of prolactin. Membrane glucocorticoid receptors (mGRs) in both mouse and human lymphoma cells are necessary for the initiation of glucocorticoid-induced therapeutic apoptosis which is related to the developmental phenomenon of thymic involution. Diseases of autoimmunity such as systemic lupus erythematosus and arthritis are related to estrogen status. Since both of these mSRs have recently been found in both normal and cancerous lymphoid cells, actions of these mSRs may have important consequences for functions and diseases of the immune system. Therefore, the study of these forms of steroid receptors may present novel therapeutic opportunities for the use of steroids and steroid analogs.",
    keywords = "Cancer, Development, Non-genomic, Prolactin release, Steroid receptors, Therapeutic apoptosis",
    author = "Watson, {Cheryl S.} and Bahiru Gametchu",
    year = "2001",
    month = "6",
    doi = "10.1016/S1567-5769(01)00036-4",
    language = "English (US)",
    volume = "1",
    pages = "1049--1063",
    journal = "International Immunopharmacology",
    issn = "1567-5769",
    publisher = "Elsevier",
    number = "6",

    }

    TY - JOUR

    T1 - Membrane estrogen and glucocorticoid receptors - Implications for hormonal control of immune function and autoimmunity

    AU - Watson, Cheryl S.

    AU - Gametchu, Bahiru

    PY - 2001/6

    Y1 - 2001/6

    N2 - Membrane steroid receptors (mSRs) have recently re-emerged as candidates for mediating steroid effects which do not fit the paradigm of nuclear transcription factor mechanisms. We have studied two steroid-binding classes of mSRs, and have noted striking similarities in their characteristics (immunocytochemical appearance, biochemical properties, proteolytic sensitivity, signaling pathways, regulation, and molecular origins). These observations strengthen the conclusion that mSRs can be modified versions of intracellular steroid receptors. The membrane estrogen receptors (mERs) we studied are involved in estrogen-induced release of prolactin. Membrane glucocorticoid receptors (mGRs) in both mouse and human lymphoma cells are necessary for the initiation of glucocorticoid-induced therapeutic apoptosis which is related to the developmental phenomenon of thymic involution. Diseases of autoimmunity such as systemic lupus erythematosus and arthritis are related to estrogen status. Since both of these mSRs have recently been found in both normal and cancerous lymphoid cells, actions of these mSRs may have important consequences for functions and diseases of the immune system. Therefore, the study of these forms of steroid receptors may present novel therapeutic opportunities for the use of steroids and steroid analogs.

    AB - Membrane steroid receptors (mSRs) have recently re-emerged as candidates for mediating steroid effects which do not fit the paradigm of nuclear transcription factor mechanisms. We have studied two steroid-binding classes of mSRs, and have noted striking similarities in their characteristics (immunocytochemical appearance, biochemical properties, proteolytic sensitivity, signaling pathways, regulation, and molecular origins). These observations strengthen the conclusion that mSRs can be modified versions of intracellular steroid receptors. The membrane estrogen receptors (mERs) we studied are involved in estrogen-induced release of prolactin. Membrane glucocorticoid receptors (mGRs) in both mouse and human lymphoma cells are necessary for the initiation of glucocorticoid-induced therapeutic apoptosis which is related to the developmental phenomenon of thymic involution. Diseases of autoimmunity such as systemic lupus erythematosus and arthritis are related to estrogen status. Since both of these mSRs have recently been found in both normal and cancerous lymphoid cells, actions of these mSRs may have important consequences for functions and diseases of the immune system. Therefore, the study of these forms of steroid receptors may present novel therapeutic opportunities for the use of steroids and steroid analogs.

    KW - Cancer

    KW - Development

    KW - Non-genomic

    KW - Prolactin release

    KW - Steroid receptors

    KW - Therapeutic apoptosis

    UR - http://www.scopus.com/inward/record.url?scp=0035022926&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=0035022926&partnerID=8YFLogxK

    U2 - 10.1016/S1567-5769(01)00036-4

    DO - 10.1016/S1567-5769(01)00036-4

    M3 - Article

    C2 - 11407301

    AN - SCOPUS:0035022926

    VL - 1

    SP - 1049

    EP - 1063

    JO - International Immunopharmacology

    JF - International Immunopharmacology

    SN - 1567-5769

    IS - 6

    ER -